Irit Arbel - 15 Dec 2021 Form 4 Insider Report for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Role
Director
Signature
/s/ Irit Arbel
Issuer symbol
BCLI
Transactions as of
15 Dec 2021
Net transactions value
$0
Form type
4
Filing time
17 Dec 2021, 16:00:38 UTC
Previous filing
10 Dec 2021
Next filing
03 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCLI Stock Option (right to buy) Award $0 +25,333 $0.000000 25,333 15 Dec 2021 Common Stock 25,333 $0.7500 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests and becomes exercisable in 12 consecutive, equal monthly installments commencing on January 15, 2022 until fully vested and exercisable on the 12 month anniversary of December 15, 2021.